Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
McKesson
AstraZeneca
Dow
Moodys

Last Updated: January 29, 2022

DrugPatentWatch Database Preview

Claims for Patent: 5,919,815

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 5,919,815
Title: Taxane compounds and compositions
Abstract:The invention provides taxanes that are conjugates of cis-docosahexaenoic acid and paclitaxel. The conjugates are useful in treating cancer.
Inventor(s): Bradley; Matthews O. (Laytonville, MD), Shashoua; Victor E. (Brookline, MA), Swindell; Charles S. (Merion, PA), Webb; Nigel L. (Bryn Mawr, PA)
Assignee: Neuromedica, Inc. (Conshohocken, PA)
Application Number:08/653,951
Patent Claims:1. A composition of matter comprising

a covalent conjugate of cis-docosahexaenoic acid and paclitaxel.

2. The composition of matter of claim 1, wherein the composition is ##STR8##

3. The composition of matter of claim 1, wherein the composition is

4. A pharmaceutical composition comprising a conjugate of cis-docosahexaenoic acid and paclitaxel, and

a sterile, pharmaceutically acceptable carrier.

5. The pharmaceutical composition of claim 4, wherein the conjugate is ##STR9##

6. The pharmaceutical composition of claim 4, wherein the conjugate is

7. The pharmaceutical composition of claim 4 further comprising an anti-cancer agent other than the conjugate.

8. The pharmaceutical of claim 7 wherein the anti-cancer agent is selected from the group consisting of: Aminoglutethimide; Asparaginase; Bleomycin; L-Buthiamine Sulfoxide; Busulfan; Camptothecin; Carboplatin; Carmustine (BCNU); Chlorambucil; Cisplatin (cis-DDP); Cyclophosphamide; Cytarabine HCI; Dacarbazine; Dactinomycin; Daunorubicin HCI; Doxorubicin HCI; Edatrexate; Estramustine phosphate sodium; Etoposide (V16-213); Floxuridine; Fluorouracil (5-FU); Flutamide; Gallium Nitrite; Hydroxyurea (hydroxycarbamide); Idarubicin; Ifosfamide; Interferon Alfa-2a, Alfa 2b; Leuprolide acetate (LHRH-releasing factor analogue); Lomustine (CCNU); Mechlorethamine HCI (nitrogen mustard); Megestrol; melphalan; Mercaptopurine; Methotrexate (MTX); Mitomycin; Mitotane (o.p'-DDD); Mitoxantrone HCI; Octreotide; Plicamycin; Prednisone; Procarbazine HCI; Streptozocin; Tamoxifen citrate; Taxanes; Taxiods; Thioguanine; Thiotepa; Tiasofuran; Topotecan; Vinblastine sulfate; Vincristine sulfate; Amsacrine (m-AMSA); Azacitidine; Hexamethylmelamine (HMM); Interleukin 2; Mitoguazone (methyl-GAG); Methyl glyoxal bis-guanylhydrazone (MGBG); Pentostatin; Semustine (methyl-CCNU); and Teniposide (VM-26).

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
Harvard Business School
McKesson
Medtronic
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.